The 5 Best Small-Cap Biotech IPOs of 2017
In a busy year for IPOs, small cap biotech IPOs have been popping up everywhere. Here are five of them that I really like.
Read More
In a busy year for IPOs, small cap biotech IPOs have been popping up everywhere. Here are five of them that I really like.
Read More
Last week I presented the three top-performing stocks of 2016, which came from very surprising places. Here are five more from a strong year on Wall Street.
Read More
The list of top-performing stocks in a given year is usually full of ambitious clinical-stage biotechs and obscure emerging market stocks. Not last year.
Read More
Recently, an investor told me that he prefers low-priced stocks. I'll call him John ... because his name is John.
Like hundreds of investors whom I've spoken with, John is concerned that he cannot earn the same profit on his principal in a high-priced than...
Read More
With biopharmaceutical stocks doing well as a group, I think playing the trend by buying the companies that provide support services just makes sense. It spreads your risk around a little. And in a touchy market environment, risk control should be top...
Read More